Published in Epidemiology on January 01, 1995
Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence. J Cachexia Sarcopenia Muscle (2012) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol (1996) 7.12
Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med (1993) 4.30
Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci (2001) 4.01
Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology (2003) 3.99
Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol (1985) (1997) 3.63
Measuring fitness in healthy older adults: the Health ABC Long Distance Corridor Walk. J Am Geriatr Soc (2001) 3.39
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Weight change in old age and its association with mortality. J Am Geriatr Soc (2001) 3.26
Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci (2000) 3.20
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology (2003) 3.18
Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health (1994) 3.10
Self-reported causes of physical disability in older people: the Cardiovascular Health Study. CHS Collaborative Research Group. J Am Geriatr Soc (1994) 3.05
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
Cardiovascular risk factors and migraine: the GEM population-based study. Neurology (2005) 2.86
Tension pneumothorax--time for a re-think? Emerg Med J (2005) 2.80
Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology (2002) 2.68
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA (1995) 2.46
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Body mass index, weight change, and risk of mobility disability in middle-aged and older women. The epidemiologic follow-up study of NHANES I. JAMA (1994) 2.38
Syncope in migraine: the population-based CAMERA study. Neurology (2006) 2.33
Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc (1999) 2.31
The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci (1997) 2.27
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
The impact of migraine on quality of life in the general population: the GEM study. Neurology (2000) 2.24
Systematic review and meta-analysis of the effect of North American working hours restrictions on mortality and morbidity in surgical patients. Br J Surg (2012) 2.21
The association of bone mineral density and depression in an older population. J Am Geriatr Soc (2001) 2.20
Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) J Am Geriatr Soc (1996) 2.17
Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol (2000) 2.16
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab (1998) 2.14
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia (2008) 2.12
Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med (1999) 2.09
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax (2005) 2.08
State scholarship, loan forgiveness, and related programs: the unheralded safety net. JAMA (2000) 2.03
Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med (1998) 2.02
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Regression analysis of recent changes in cardiovascular morbidity and mortality in The Netherlands. BMJ (1997) 1.98
Preventing fatal diseases increases healthcare costs: cause elimination life table approach. BMJ (1998) 1.97
Coping with multiple morbidity in a life table. Math Popul Stud (1998) 1.90
Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Econ (2001) 1.89
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol (1995) 1.87
Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85
Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology (2002) 1.82
Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol (1997) 1.81
Memory complaints and memory impairment in older individuals. J Am Geriatr Soc (1996) 1.79
Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 1.76
Social support, self-esteem and depression. Psychol Med (1986) 1.73
Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology (2004) 1.73
Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology (2011) 1.69
Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol (1998) 1.67
London bombings July 2005: the immediate pre-hospital medical response. Resuscitation (2005) 1.67
Loss of parent in childhood and adult psychiatric disorder: the role of lack of adequate parental care. Psychol Med (1986) 1.64
Surgically avertable burden of obstetric conditions in low- and middle-income regions: a modelled analysis. BJOG (2015) 1.62
Befriending as an intervention for chronic depression among women in an inner city. 1: Randomised controlled trial. Br J Psychiatry (1999) 1.61
Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc (2001) 1.61
Neonatal genital prolapse. Pediatrics (1992) 1.60
Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med (2003) 1.59
Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology (2005) 1.59
Depression and loss. Br J Psychiatry (1977) 1.58
Epidemiology of Alzheimer's disease. Epidemiol Rev (1992) 1.56
Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia (2010) 1.56
Acute otitis media in children. BMJ (1997) 1.54
Evidence for inflammation as a cause of hypocholesterolemia in older people. J Am Geriatr Soc (1995) 1.49
Age, gender, and race/ethnic differences in total body and subregional bone density. Osteoporos Int (2008) 1.46
Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology (1995) 1.45
Current and future costs of cancer. Eur J Cancer (1994) 1.43
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
[Future increase of the incidence of mesothelioma due to occupational exposure to asbestos in the past]. Ned Tijdschr Geneeskd (1997) 1.39
Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int (2003) 1.39
Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging (2006) 1.38
Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia (1995) 1.38
Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol (1994) 1.36
Hippocampal shape analysis in Alzheimer's disease: a population-based study. Neuroimage (2007) 1.35
Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychol Med (2012) 1.33
Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol (1999) 1.32
The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child (2004) 1.32
Location specific radiographic joint space width for osteoarthritis progression. Osteoarthritis Cartilage (2008) 1.31
Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ (1994) 1.31
Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.29
Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology (2010) 1.29
Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes (Lond) (2007) 1.28
Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke (2001) 1.28
Social origins of depression: a reply. Psychol Med (1978) 1.28
Difficulty with holding urine among older persons in a geographically defined community: prevalence and correlates. J Am Geriatr Soc (1995) 1.26
Quantitative health impact assessment: current practice and future directions. J Epidemiol Community Health (2005) 1.24
Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology (1999) 1.24
Anthropometric indicators and hip fracture. The NHANES I epidemiologic follow-up study. J Am Geriatr Soc (1989) 1.24
Pelvic body composition measurements by quantitative computed tomography: association with recent hip fracture. Bone (2008) 1.23
Patella malalignment, pain and patellofemoral progression: the Health ABC Study. Osteoarthritis Cartilage (2007) 1.23
Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. BMJ (1997) 1.20
The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int (2007) 1.19